Avidity Biosciences Inc (RNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 10,897 | 9,560 | 9,224 | 9,326 | 6,787 |
| Gross Profit | 10,897 | 9,560 | 9,224 | 9,326 | 6,787 |
| Operating Expenses | 389,833 | 245,158 | 188,137 | 127,377 | 51,064 |
| Operating Income | -378,936 | -235,598 | -178,913 | -118,051 | -44,277 |
| Interest Expense | 0 | 0 | 0 | 0 | 209 |
| Other Income | 56,634 | 23,378 | 4,918 | 42 | 131 |
| Pre-tax Income | -322,302 | -212,220 | -173,995 | -118,009 | -44,355 |
| Net Income Continuous | -322,302 | -212,220 | -173,995 | -118,009 | -44,355 |
| Net Income | $-322,302 | $-212,220 | $-173,995 | $-118,009 | $-44,355 |
| EPS Basic Total Ops | -2.89 | -2.91 | -3.34 | -2.85 | -2.05 |
| EPS Basic Continuous Ops | -2.89 | -2.91 | -3.34 | -2.85 | -2.05 |
| EPS Diluted Total Ops | -2.89 | -2.91 | -3.34 | -2.85 | -2.05 |
| EPS Diluted Continuous Ops | -2.89 | -2.91 | -3.34 | -2.85 | -2.05 |
| EPS Diluted Before Non-Recurring Items | -2.89 | -2.91 | -3.34 | -2.85 | -2.05 |
| EBITDA(a) | $-397,607 | $-244,771 | $-178,141 | $-117,233 | $-43,895 |